文献速递艾滋病与性传播感染

使用依非韦伦的自杀行为风险:来自抗逆转录病毒治疗战略时机试验的结果

Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
PubMed 文献 · Clin Infect Dis · 2018-01-01

START试验将未治疗且CD4计数高的HIV阳性成人随机分配至立即或延迟抗逆转录病毒治疗(ART),比较自杀及自伤行为发生率。整体意向治疗分析未显示组间差异(HR 1.07,P=0.81),但亚组分析提示立即启动依非韦伦(EFV)者自杀行为风险增加,尤其有精神疾病诊断者。

要点

  • 整体意向治疗分析未显示立即与延迟ART组间自杀行为风险差异(HR 1.07,P=0.81)。
  • 在延迟组启动ART时删失后,预设EFV者立即组较延迟组HR为3.31(P=0.03)。
  • 预设其他ART方案者对应HR为1.04(P=0.93),交互作用P=0.07。

核心结论

  • 立即ART组中使用EFV的参与者较未治疗对照自杀行为风险增加。
  • 有既往精神疾病诊断者风险更高。

研究设计与样本

  • START试验将未治疗且CD4计数高的HIV阳性成人随机分配至立即与延迟ART。
  • 初始ART方案在随机化前预设。
  • 共4684名参与者,其中271名(5.8%)有既往精神疾病诊断。
  • 3515名(75%)预设使用EFV,有精神疾病诊断者中预设EFV比例(40%)低于无诊断者(77%)。

主要发现

  • 整体意向治疗比较未显示组间自杀行为差异(HR 1.07,P=0.81)。
  • 在延迟组启动ART时删失随访后,预设EFV者立即组与延迟组HR为3.31(P=0.03)。
  • 预设其他ART方案者对应HR为1.04(P=0.93),交互作用P=0.07。
  • 立即组中有既往精神疾病诊断者风险更高,无论预设治疗组别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomized trials have shown increased risk of suicidality associated with efavirenz (EFV). The START (Strategic Timing of Antiretroviral Treatment) trial randomized treatment-naive human immunodeficiency virus (HIV)-positive adults with high CD4 cell counts to immediate vs deferred antiretroviral therapy (ART). METHODS: The initial ART regimen was selected prior to randomization (prespecified). We compared the incidence of suicidal and self-injurious behaviours (suicidal behavior) between the immediate vs deferred ART groups using proportional hazards models, separately for those with EFV and other prespecified regimens, by intention to treat, and after censoring participants in the deferred arm at ART initiation. RESULTS: Of 4684 participants, 271 (5.8%) had a prior psychiatric diagnosis. EFV was prespecified for 3515 participants (75%), less often in those with psychiatric diagnoses (40%) than without (77%). While the overall intention-to-treat comparison showed no difference in suicidal behavior between arms (hazard ratio [HR], 1.07, P = .81), subgroup analyses suggest that initiation of EFV, but not other ART, is associated with increased risk of suicidal behavior. When censoring follow-up at ART initiation in the deferred group, the immediate vs deferred HR among those who were prespecified EFV was 3.31 (P = .03) and 1.04 (P = .93) among those with other prespecified ART; (P = .07 for interaction). In the immediate group, the risk was higher among those with prior psychiatric diagnoses, regardless of prespecified treatment group. CONCLUSIONS: Participants who used EFV in the immediate ART group had increased risk of suicidal behavior compared with ART-naive controls. Those with prior psychiatric diagnoses were at higher risk.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Arenas-Pinto A, Grund B, Sharma S, et al. Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial. Clin Infect Dis. 2018. PMID: 29538636. doi:10.1093/cid/ciy051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。